Bioject's vaccine delivery device beats syringe in clinical trials
This article was originally published in Clinica
Executive Summary
Portland, Oregon-based needle-free vaccine delivery company Bioject Medical Technologies has posted positive results from two studies of its Biojector 2000 (B2000) device at the AIDS Vaccine 2007 conference in Seattle, Washington.